Informations techniques
Exploitant
OMNIVISION GmbH
Présentation
BRIMONIDINE OMNIVISION 2 mg/ml, collyre en solution en récipients unidoses - 60 récipients unidoses de 0,35 ml (CIP : 34009 301 500 3 0)
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
vqxxC720b9JsYWS9